Jeffrey Hackman - May 19, 2022 Form 3/A - Amendment Insider Report for Comera Life Sciences Holdings, Inc. (CMRA)

Signature
/s/ Ryan M. Rourke Reed, Attorney-in-Fact
Stock symbol
CMRA
Transactions as of
May 19, 2022
Transactions value $
$0
Form type
3/A - Amendment
Date filed
2/14/2023, 04:12 PM
Date Of Original Report
May 20, 2022
Next filing
Aug 11, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CMRA Stock Option (Right to Buy) May 19, 2022 Common Stock 278K $0.59 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 3/A is being filed to correct information previously disclosed on the original Form 3 filed by the reporting person on May 20, 2022, including the Exercise Price, Expiration Date, Amount or Number of Shares and vesting schedule of the stock option grant.
F2 This option was issued pursuant to the terms of a business combination agreement involving the issuer and Comera Life Sciences, Inc. in exchange for a comparable option previously issued by such company on September 16, 2021. 25% of the option vests or vested on the one year anniversary of the grant date and in equal monthly installments thereafter for 36 months.

Remarks:

Chairman, President and Chief Executive Officer.